Biocon Reports Strong Financial Results, Indicating Improved Operational Performance and Growth Potential

May 09 2025 08:16 AM IST
share
Share Via
Biocon has announced its financial results for the quarter ending March 2025, revealing significant growth in key metrics. Profit Before Tax reached Rs 429.50 crore, while Profit After Tax was Rs 325.25 crore. The company also reported its highest net sales in five quarters at Rs 4,417.00 crore, alongside improved operational efficiency.
Biocon, a prominent player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 8, 2025, indicate a notable shift in the company's evaluation, with a revision in its score reflecting a positive trajectory over the past three months.

The financial data reveals significant growth in key metrics. Profit Before Tax less Other Income (PBT) reached Rs 429.50 crore, showcasing a substantial increase compared to the average of the previous four quarters. This trend is mirrored in the Profit After Tax (PAT), which stood at Rs 325.25 crore, marking a considerable rise over the same period. Additionally, Biocon achieved its highest net sales in the last five quarters, amounting to Rs 4,417.00 crore, indicating a robust sales performance.

The company's operational efficiency is also highlighted by an Operating Profit Margin of 24.41%, the highest recorded in the last five quarters. Furthermore, the Operating Profit to Interest ratio has improved, reaching 5.08 times, suggesting enhanced capability in managing interest obligations.

Overall, Biocon's recent financial results reflect a positive shift in its operational performance and financial health.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News